Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Director departure
|
|
CASI Pharmaceuticals, Inc (DE) (CASI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/09/2022 |
4
| Zukiwski Alexander A (EVP and Chief Medical Officer) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Granted 3,000 options to buy
@ $0 |
|
| 09/08/2022 |
4
| Huang James (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Bought 19,162 shares
@ $3.8932, valued at
$74.6k
Bought 3,111 shares
@ $3.9965, valued at
$12.4k
Bought 33,300 shares
@ $4.2831, valued at
$142.6k
|
|
| 09/02/2022 |
4
| Huang James (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Bought 24,975 shares
@ $3.745, valued at
$93.5k
Bought 11,821 shares
@ $3.7229, valued at
$44k
Bought 400 shares
@ $3.7413, valued at
$1.5k
|
|
| 08/26/2022 |
4
| Huang James (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Bought 5,000 shares
@ $3.7502, valued at
$18.8k
Bought 39,527 shares
@ $3.7488, valued at
$148.2k
|
|
| 08/23/2022 |
4
| Huang James (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Bought 171,116 shares
@ $3.2694, valued at
$559.4k
Bought 23,105 shares
@ $3.4641, valued at
$80k
Bought 40,000 shares
@ $3.4998, valued at
$140k
|
|
| 06/17/2022 |
4
| He Wei-Wu (Chairman and CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Bought 36,058 shares
@ $2.97, valued at
$107.1k
Bought 2,096 shares
@ $3.06, valued at
$6.4k
Bought 50,000 shares
@ $3.18, valued at
$159k
|
|
| 05/26/2022 |
4
| Zhou Quan (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Granted 380,645 options to buy
@ $0.4664, valued at
$177.5k
|
|
| 05/26/2022 |
4
| Huang James (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Granted 397,419 options to buy
@ $0.4664, valued at
$185.4k
|
|
| 05/26/2022 |
4
| Wu Yue Alexander (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Granted 388,387 options to buy
@ $0.4664, valued at
$181.1k
|
|
| 05/26/2022 |
4
| Salisbury Franklin Cary jr (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Granted 388,387 options to buy
@ $0.4664, valued at
$181.1k
|
|
| 05/26/2022 |
4
| SHROTRIYA RAJESH C MD (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Granted 345,806 options to buy
@ $0.4664, valued at
$161.3k
|
|
| 12/06/2021 |
4
| Zukiwski Alexander A (Chief Medical Officer) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Granted 500,000 options to buy
@ $0.87, valued at
$435k
|
|
| 11/19/2021 |
4
| He Wei-Wu (Chairman and CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Bought 200,000 shares
@ $0.99, valued at
$198k
Bought 200,000 shares
@ $0.98, valued at
$196k
|
|
| 08/20/2021 |
4
| He Wei-Wu (Chairman and CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Bought 300,000 shares
@ $1.29, valued at
$387k
Bought 180,000 shares
@ $1.26, valued at
$226.8k
|
|
| 07/26/2021 |
4
| Zhang Larry (President) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Granted 800,000 options to buy
@ $1.28, valued at
$1M
|
|
| 06/16/2021 |
4
| Zhou Quan (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Granted 108,257 options to buy
@ $1.65, valued at
$178.6k
|
|
| 06/16/2021 |
4
| Wu Yue Alexander (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Granted 110,459 options to buy
@ $1.65, valued at
$182.3k
|
|
| 06/16/2021 |
4
| SHROTRIYA RAJESH C MD (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Granted 98 options to buy
@ $1.65, valued at
$162.3 |
|
| 06/16/2021 |
4
| Salisbury Franklin Cary jr (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Granted 110,459 options to buy
@ $1.65, valued at
$182.3k
|
|
| 06/16/2021 |
4
| Huang James (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Granted 113,028 options to buy
@ $1.65, valued at
$186.5k
|
|
| 06/16/2021 |
4
| He Wei-Wu (Chairman and CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Granted 4,000,000 options to buy
@ $1.73, valued at
$6.9M
|
|
| 03/30/2021 |
4
| He Wei-Wu (Chairman and CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Bought 3,000,000 shares
@ $2.05, valued at
$6.2M
|
|
| 12/23/2020 |
4
| He Wei-Wu (Chairman and CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Gifted 380,000 shares
@ $0 |
|
| 12/18/2020 |
4
| Xu Weihao (CFO) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Bought 2,000 shares
@ $2.44, valued at
$4.9k
Bought 1,721 shares
@ $2.64, valued at
$4.5k
Bought 2,279 shares
@ $2.63, valued at
$6k
Granted 800,000 options to buy
@ $2.61, valued at
$2.1M
|
|
| 12/18/2020 |
3
| Xu Weihao (CFO) has filed a Form 3 on CASI Pharmaceuticals, Inc. |
| 11/24/2020 |
4
| He Wei-Wu (Chairman and CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Bought 127,471 shares
@ $2.12, valued at
$270.2k
Bought 100,000 shares
@ $2.18, valued at
$218k
|
|
| 07/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| Zhou Quan (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Granted 67,429 options to buy
@ $2.63, valued at
$177.3k
|
|
| 06/18/2020 |
4
| Huang James (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Granted 70,400 options to buy
@ $2.63, valued at
$185.2k
|
|
| 06/18/2020 |
4
| Wu Yue Alexander (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Granted 68,800 options to buy
@ $2.63, valued at
$180.9k
|
|
| 06/18/2020 |
4
| Salisbury Franklin Cary jr (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Granted 68,800 options to buy
@ $2.63, valued at
$180.9k
|
|
| 06/18/2020 |
4
| SHROTRIYA RAJESH C MD (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Granted 61,257 options to buy
@ $2.63, valued at
$161.1k
|
|
| 05/21/2020 |
4
| He Wei-Wu (Chairman and CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Bought 29,801 shares
@ $2.03, valued at
$60.5k
Bought 56,464 shares
@ $2.37, valued at
$133.8k
|
|
|
|
|